Voyager Therapeutics Inc

Most Recent

  • uploads///utah _
    Company & Industry Overviews

    Why Is Voyager Therapeutics Soaring Today?

    Today, Voyager Therapeutics (VYGR) issued a press release announcing a strategic collaboration with Neurocrine Biosciences (NBIX).

    By Margaret Patrick
  • uploads///BMRN ana reco
    Company & Industry Overviews

    Analysts Remain Bullish on BioMarin Pharmaceutical

    Of the 23 analysts covering BioMarin Pharmaceutical (BMRN) in September, 19 of them have given the stock a “buy” or higher rating.

    By Kenneth Smith
  • uploads///Audentes ana reco
    Company & Industry Overviews

    Analyzing Audentes Therapeutics’ Valuation Metrics

    Audentes Therapeutics (BOLD) incurred a net loss of $31.37 million in the second quarter compared with $22.74 million in Q2 2017.

    By Kenneth Smith
  • uploads///VYGR
    Company & Industry Overviews

    Exploring Voyager Therapeutics’ Research Pipeline

    Voyager Therapeutics’ (VYGR) research pipeline consists of six programs targeting different neurological indications.

    By Kenneth Smith
  • uploads///mental health _
    Company & Industry Overviews

    Analysts Rate Voyager Therapeutics and Its Peers in April

    Voyager Therapeutics is a clinical-stage gene therapy company with a focus on developing treatments for severe neurological diseases.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.